Parnell Pharmaceuticals (CE) Quote - PARNF

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.165

Bid

0.00

Offer

0.00

Volume

0.00 Day's Range 0.00

0.000001 52 Week Range 0.35

Market Cap

19.862M

Previous Close

0.165

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

26,788

Shares Outstanding

120,377,529

Dividend Yield

PE Ratio

-3.35

Earnings Per Share (EPS)

-0.05

Revenue

35.43M

Net Profit

-5.74M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.parnell.com

Headquarters

Sydney, New South Wales, Aus

Founded

Parnell Pharmaceuticals Holdings Ltd (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker PARNF. The last closing price for Parnell Pharmaceuticals (CE) was US$0.17. Over the last year, Parnell Pharmaceuticals (CE) shares have traded in a share price range of US$ 0.000001 to US$ 0.35.

Parnell Pharmaceuticals (CE) currently has 120,377,529 shares in issue. The market capitalisation of Parnell Pharmaceuticals (CE) is US$19.86 million. Parnell Pharmaceuticals (CE) has a price to earnings ratio (PE ratio) of -3.35.

Parnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQ

OVERLAND PARK, Kan., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the...

OVERLAND PARK, Kan., Dec. 09, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility

OVERLAND PARK, Kan., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Nine-Month Period Ended September 30, 2016

OVERLAND PARK, Kansas, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

Parnell to Report Financial Results for the Nine Months Ended September 30, 2016 on November 2, 2016

OVERLAND PARK, Kan., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2016

OVERLAND PARK, Kan., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016

OVERLAND PARK, Kan., July 26, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...

Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial

OVERLAND PARK, Kan., May 31, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

Parnell Pharmaceuticals Holdings Ltd Announces Pricing of an Underwritten Public Offering of Common Stock

OVERLAND PARK, Kan., May 12, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing...

Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Update

Parnell continues to grow rapidly with revenue increasing 43% for the three months ended March 31, 2016OVERLAND PARK, Kan., April 22, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.025	-13.1578947368	0.19	0.19	0.165	10000	0.165	CS
4	0.083	101.219512195	0.082	0.19	0.082	17664	0.14489538	CS
12	0.115	230	0.05	0.35	0.05	26788	0.09030129	CS
26	0.1649	164900	0.0001	0.35	1.0E-6	19978	0.08879462	CS
52	0.164999	16499900	1.0E-6	0.35	1.0E-6	14637	0.08657164	CS
156	0.1649	164900	0.0001	0.35	1.0E-6	13296	0.03021553	CS
260	0.015	10	0.15	0.89	1.0E-6	12510	0.2151439	CS

PARNF - Frequently Asked Questions (FAQ)

What is the current Parnell Pharmaceuticals (CE) share price?

The current share price of Parnell Pharmaceuticals (CE) is US$ 0.165

How many Parnell Pharmaceuticals (CE) shares are in issue?

Parnell Pharmaceuticals (CE) has 120,377,529 shares in issue

What is the market cap of Parnell Pharmaceuticals (CE)?

The market capitalisation of Parnell Pharmaceuticals (CE) is USD 19.86M

What is the 1 year trading range for Parnell Pharmaceuticals (CE) share price?

Parnell Pharmaceuticals (CE) has traded in the range of US$ 0.000001 to US$ 0.35 during the past year

What is the PE ratio of Parnell Pharmaceuticals (CE)?

The price to earnings ratio of Parnell Pharmaceuticals (CE) is -3.35

What is the cash to sales ratio of Parnell Pharmaceuticals (CE)?

The cash to sales ratio of Parnell Pharmaceuticals (CE) is 0.54

What is the reporting currency for Parnell Pharmaceuticals (CE)?

Parnell Pharmaceuticals (CE) reports financial results in AUD

What is the latest annual turnover for Parnell Pharmaceuticals (CE)?

The latest annual turnover of Parnell Pharmaceuticals (CE) is AUD 35.43M

What is the latest annual profit for Parnell Pharmaceuticals (CE)?

The latest annual profit of Parnell Pharmaceuticals (CE) is AUD -5.74M

What is the registered address of Parnell Pharmaceuticals (CE)?

The registered address for Parnell Pharmaceuticals (CE) is UNIT 4 CENTURY ESTATE, 476 GARDENERS ROAD, ALEXANDRIA, SYDNEY, NEW SOUTH WALES, 2015

What is the Parnell Pharmaceuticals (CE) website address?

The website address for Parnell Pharmaceuticals (CE) is www.parnell.com

Which industry sector does Parnell Pharmaceuticals (CE) operate in?

Parnell Pharmaceuticals (CE) operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AABVFAberdeen International Inc (PK)	US$ 0.0242 (0.00%)	0
AABKFAareal Bank AG (PK)	US$ 0.00 (0.00%)	0
AABBAsia Broadband Inc (PK)	US$ 0.02855 (0.00%)	0
AAALYAareal Bank AG (PK)	US$ 34.65 (0.00%)	0
AAAIFAlternative Investment Trust (PK)	US$ 0.55 (0.00%)	0
AABVFAberdeen International Inc (PK)	US$ 0.0242 (0.00%)	0
AABKFAareal Bank AG (PK)	US$ 0.00 (0.00%)	0
AABBAsia Broadband Inc (PK)	US$ 0.02855 (0.00%)	0
AAALYAareal Bank AG (PK)	US$ 34.65 (0.00%)	0
AAAIFAlternative Investment Trust (PK)	US$ 0.55 (0.00%)	0
DTEGYDeutsche Telekom AG (QX)	US$ 31.48 (0.00%)	787.81k
PROSYProsus NV (PK)	US$ 7.27 (0.00%)	9.1k
REMYYRemy Cointreau SA (PK)	US$ 5.60 (0.00%)	4.7k
PPRUYKering (PK)	US$ 25.78 (0.00%)	3.46k
JARLFJardine Matheson Holdings Ltd (PK)	US$ 39.385 (0.00%)	2.7k